核イメージング装置の世界市場 - 市場規模：製品別、用途別、エンドユーザー別、地域別、予測

核イメージング装置の市場規模と予測

核イメージング装置市場規模は、2024年に28億6,000万米ドルと評価され、2026年から2032年にかけてCAGR 4.85%で成長し、2032年には40億3,000万米ドルに達すると予測されています。

核イメージング装置は、体内の臓器や組織の機能を視覚化し評価するために核医学で使用される特殊な医療機器を指します。このイメージング技術は、放射性医薬品または放射性トレーサーとして知られる少量の放射性物質を利用するもので、ガンマ線を放出し、装置によって検出されて画像を作成します。

核イメージング装置は、臓器の構造的な外観だけでなく、臓器の生理学的機能に基づいた画像を撮影するように設計されており、X線やCTスキャンなどの従来の画像診断法とは異なります。

核イメージング装置は、がん、心臓病、その他を含む様々な疾患の診断に広く使用されています。核イメージング装置によって、医療プロバイダーは臓器の機能をモニターし、疾患の進行を評価することができます。

核医学画像診断は一般的に非侵襲的で痛みを伴わないため、現代の診断における貴重なツールとなっています。

核イメージング装置の世界市場力学

世界の核イメージング装置市場を形成している主な市場力学は以下の通り：

主な市場促進要因

診断手順に対する需要の増加：年間3,000万人以上の患者が核医学と分子イメージング技術を使用して診断または治療を受けており、正確な診断と治療計画のためにこれらの技術への依存が高まっていることが浮き彫りになっています。

技術の進歩：SPECT/CTやPET/CTなどの高度な画像技術の開発と統合により、診断能力が向上しています。国際原子力機関（IAEA）の報告によると、SPECTシステムは全世界で2万7,000台以上、PETシステムは5,200台以上が設置されており、これらの技術が広く採用されていることを示しています。

慢性疾患の増加：慢性疾患、特にがんや心血管疾患の増加は、効果的な診断への需要を促進します。核医学画像診断は、診断、病期分類、治療モニタリングのために腫瘍学において重要であり、現代医療に不可欠な要素となっています。

支持的な規制環境：米国原子力規制委員会（NRC）や食品医薬品局（FDA）などの規制機関は、核画像技術の安全な使用を促進するガイドラインを提供しています。このような規制支援は技術革新を促進し、医療施設に新しい機器への投資を促します。

主な市場課題

厳しい規制遵守：核イメージング分野は、米国原子力規制委員会（NRC）や食品医薬品局（FDA）などの厳しい規制の対象です。これらの規制は、機器の校正や投与量の文書化など、安全基準の厳格な遵守を義務付けています。NRCは、放射線量が指定された閾値以下であることを確認するため、施設に対して定期的なエリア調査を義務付けており、医療提供者の業務手順を複雑にしています。

高い設備コスト：PETスキャナーやSPECTスキャナーのような核イメージング装置の初期投資と保守費用は、多くの医療施設、特に発展途上地域にとっては法外に高いです。このような経済的障壁は、高度な診断技術へのアクセスを制限し、市場全体に影響を与えます。

技術の複雑さ：核イメージング技術の急速な進歩により、医療スタッフに対する継続的なトレーニングと教育が必要となります。高度な機器の操作が複雑なため、医療スタッフが十分な訓練を受けていないとミスにつながり、患者の安全性と診断精度が損なわれる可能性があります。

代替画像診断法との競合：MRIやCTスキャンなどの非核イメージング技術は、解像度が飛躍的に向上し、医療提供者にとって魅力的な選択肢となることが多いため、核イメージング技術の市場シェアが低下する可能性があります。これらのモダリティの採用が進むと、資金や関心が核イメージングからそれる可能性があります。

主な市場動向：

先端技術の統合：核イメージングシステム、特にSPECTイメージングに人工知能（AI）と機械学習を統合する傾向が強まっています。この統合により、画像解析が強化され、診断精度が向上し、業務効率が高まる。米国国立衛生研究所（NIH）は、高度な画像診断技術によって患者の予後を改善するため、この分野の研究に積極的に資金を提供しています。

ハイブリッド画像システム：SPECT/CTやPET/CTなどのハイブリッド画像システムの開発と採用が増加しています。これらのシステムは核医学による機能的画像とCTスキャンによる解剖学的画像を組み合わせたもので、総合的な診断情報を提供します。国際原子力機関（IAEA）によると、ハイブリッドシステムは様々な医療分野において診断精度と局在性を著しく向上させています。

新しい放射性医薬品の出現：新規放射性医薬品の導入は、核イメージングの応用を拡大しています。これらの進歩により、特定の疾患により的を絞った画像診断が可能となり、診断方法の有効性が高まっています。米国食品医薬品局（FDA）は近年、いくつかの新しい放射性医薬品を承認しており、この分野における技術革新が進んでいることを反映しています。

患者安全の重視：核医学画像検査中の患者への放射線被曝低減がますます重視されています。NRCのような規制機関は、合理的に達成可能な限り被曝線量を低く抑える（ALARA）ことを提唱しており、これが画質を損なうことなく安全性を向上させることを目的とした技術進歩の原動力となっています。

目次

第1章 核イメージング装置の世界市場のイントロダクション

• 市場概要
• 調査範囲
• 前提条件

第2章 エグゼクティブサマリー

第3章 VERIFIED MARKET RESEARCHの調査手法

• データマイニング
• バリデーション
• 一次資料
• データソース一覧

第4章 核イメージング装置の世界市場展望

• 概要
• 市場力学
  • 促進要因
  • 抑制要因
  • 機会
• ポーターのファイブフォースモデル
• バリューチェーン分析

第5章 核イメージング装置の世界市場：製品別

• 概要
• SPECTシステム
• ハイブリッドPETシステム
• プラナーシンチグラフィ

第6章 核イメージング装置の世界市場：用途別

• 概要
• 腫瘍
• 心臓
• 神経
• その他

第7章 核イメージング装置の世界市場：エンドユーザー別

• 概要
• 病院
• イメージングセンター
• 学術研究センター
• その他

第8章 核イメージング装置の世界市場：地域別

• 概要
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • その他欧州
• アジア太平洋
  • 中国
  • 日本
  • インド
  • その他アジア太平洋地域
• 世界のその他の地域
  • ラテンアメリカ
  • 中東・アフリカ

第9章 核イメージング装置の世界市場の競合情勢

• 概要
• 各社の市場ランキング
• 主な発展戦略

第10章 企業プロファイル

• Siemens AG
• GE Healthcare
• Philips Healthcare
• Digirad Corporation
• Surgiceye GmbH

第11章 付録

• 関連調査

Nuclear Imaging Equipment Market Size And Forecast

Nuclear Imaging Equipment Market size was valued at USD 2.86 Billion in 2024 and is projected to reach USD 4.03 Billion by 2032, growing at a CAGR of 4.85% from 2026 to 2032.

Nuclear imaging equipment refers to specialized medical devices used in nuclear medicine to visualize and assess the function of organs and tissues within the body. This imaging technique utilizes small amounts of radioactive materials, known as radiopharmaceuticals or radiotracers, which emit gamma rays that are detected by the equipment to create images.

Nuclear imaging equipment is designed to capture images based on the physiological function of organs rather than just their structural appearance, distinguishing it from traditional imaging modalities like X-rays or CT scans.

Nuclear imaging equipment is widely used for diagnosing various conditions, including cancers, heart disease, and other It allows healthcare providers to monitor organ function and assess disease progression.

Nuclear imaging is generally non-invasive and painless, making it a valuable tool in modern diagnostics.

Global Nuclear Imaging Equipment Market Dynamics

The key market dynamics that are shaping the global nuclear imaging equipment market include:

Key Market Drivers:

Increasing Demand for Diagnostic Procedures: Over 30 million patients are diagnosed or treated annually using nuclear medicine and molecular imaging techniques, highlighting the growing reliance on these technologies for accurate diagnosis and treatment planning.

Advancements in Technology: The development and integration of advanced imaging technologies, such as SPECT/CT and PET/CT, have enhanced diagnostic capabilities. The International Atomic Energy Agency (IAEA) reports that over 27,000 SPECT systems and more than 5,200 PET systems are installed worldwide, indicating widespread adoption of these technologies.

Growing Prevalence of Chronic Diseases: The rise in chronic diseases, particularly cancers and cardiovascular disorders, drives the demand for effective diagnostic Nuclear imaging is critical in oncology for diagnosis, staging, and treatment monitoring, making it an essential component of modern healthcare.

Supportive Regulatory Environment: Regulatory bodies, such as the S. Nuclear Regulatory Commission (NRC) and the Food and Drug Administration (FDA), provide guidelines that facilitate the safe use of nuclear imaging technologies. This regulatory support fosters innovation and encourages healthcare facilities to invest in new equipment.

Key Market Challenges:

Stringent Regulatory Compliance: The nuclear imaging sector is subject to rigorous regulations imposed by bodies like the U.S. Nuclear Regulatory Commission (NRC) and the Food and Drug Administration (FDA). These regulations require strict adherence to safety standards, including calibration of equipment and documentation of administered dosages. The NRC mandates that facilities conduct regular area surveys to ensure radiation doses remain below specified thresholds, complicating operational procedures for healthcare providers.

High Equipment Costs: The initial investment and maintenance costs for nuclear imaging equipment, such as PET and SPECT scanners, can be prohibitively high for many healthcare facilities, especially in developing regions. This financial barrier limits access to advanced diagnostic technologies, impacting overall market

Technological Complexity: The rapid advancements in nuclear imaging technology necessitate continuous training and education for medical staff. The complexity of operating sophisticated equipment can lead to errors if personnel are not adequately trained, which can compromise patient safety and diagnostic accuracy.

Competition from Alternative Imaging Modalities: Non-nuclear imaging techniques, such as MRI and CT scans, have seen significant advancements in resolution and These alternatives often provide compelling options for healthcare providers, leading to potential market share loss for nuclear imaging technologies. The increasing adoption of these modalities can divert funding and attention away from nuclear imaging.

Key Market Trends:

Integration of Advanced Technologies: There is a growing trend towards integrating artificial intelligence (AI) and machine learning into nuclear imaging systems, particularly in SPECT imaging. This integration enhances image analysis, improves diagnostic accuracy, and increases operational efficiency. The National Institutes of Health (NIH) is actively funding research in this area to improve patient outcomes through advanced imaging techniques.

Hybrid Imaging Systems: The development and adoption of hybrid imaging systems, such as SPECT/CT and PET/CT, are on the rise. These systems combine functional imaging from nuclear medicine with anatomical imaging from CT scans, providing comprehensive diagnostic information. According to the International Atomic Energy Agency (IAEA), hybrid systems have significantly improved diagnostic accuracy and localization in various medical fields.

Emergence of New Radiopharmaceuticals: The introduction of novel radiopharmaceuticals is expanding the applications of nuclear imaging. These advancements allow for more targeted imaging of specific diseases, enhancing the effectiveness of diagnostic procedures. The U.S. Food and Drug Administration (FDA) has approved several new radiotracers in recent years, reflecting the ongoing innovation in this area.

Focus on Patient Safety: There is an increasing emphasis on reducing radiation exposure to patients during nuclear imaging procedures. Regulatory bodies like the NRC advocate for practices that keep radiation doses as low as reasonably achievable (ALARA), which is driving technological advancements aimed at improving safety without compromising image quality.

Global Nuclear Imaging Equipment Market Regional Analysis

Here is a more detailed regional analysis of the global nuclear imaging equipment market:

North America:

North America accounted for approximately 42% of the global nuclear imaging equipment market in 2023. This significant share reflects the region's advanced healthcare infrastructure and high demand for diagnostic imaging

The region faces a growing incidence of chronic diseases, particularly cancer and cardiovascular The International Agency for Research on Cancer projects that by 2025, the worldwide cancer prevalence will reach over 50 million, driving the need for effective diagnostic tools like nuclear imaging.

North America is at the forefront of technological advancements in nuclear imaging, including the development of hybrid systems like SPECT/CT and PET/CT. These innovations enhance diagnostic accuracy and are supported by funding from organizations such as the National Institutes of Health (NIH), which promotes research in advanced imaging techniques.

The increasing elderly population in North America contributes to a higher demand for diagnostic procedures. As older adults are more susceptible to chronic diseases requiring regular monitoring, this demographic trend further fuels the growth of nuclear imaging services.

Europe:

Europe is expected to account for a substantial portion of the global nuclear imaging equipment market, driven by a high number of product launches and advancements in technology. For instance, the region's market share is projected to grow significantly due to innovations from companies like Siemens Healthineers and Philips

The European Medicines Agency (EMA) and national regulatory bodies enforce stringent regulations that ensure high safety and efficacy standards for nuclear imaging This regulatory environment fosters innovation while ensuring patient safety.

The rise in chronic diseases, particularly cancer and cardiovascular conditions, is a significant driver of demand for nuclear imaging. According to the World Health Organization (WHO), cancer was responsible for approximately 1 in 6 deaths globally in 2020, highlighting the need for effective diagnostic tools.

The aging population in Europe is driving demand for diagnostic imaging services. By 2030, it is estimated that over 25% of the EU population will be over 65 years old, increasing the prevalence of age-related diseases that require advanced imaging

Global Nuclear Imaging Equipment Market: Segmentation Analysis

The Global Nuclear Imaging Equipment Market is Segmented based on Product, Application, End-User, And Geography.

Nuclear Imaging Equipment Market, By Product

• SPECT Imaging Systems
• PET Imaging Systems
• Planar Scintigraphy Imaging Systems

Based on Product, the global Nuclear Imaging Equipment market is divided into SPECT Imaging Systems, PET Imaging Systems, and Planar Scintigraphy Imaging Systems. SPECT imaging systems hold a significant share of the nuclear imaging market, driven by their widespread use in various diagnostic applications, including cardiology, oncology, and neurology. The global SPECT market is projected to grow from approximately $2.1 billion in 2022 to $4.7 billion by 2032, reflecting a robust CAGR of 8.5% during this period.

Nuclear Imaging Equipment Market, By Application

• Oncology
• Cardiology
• Neurology

Based on Application, the market is segmented into Oncology, Cardiology, and Neurology. The oncology segment is expected to account for a significant portion of the nuclear imaging equipment market, with estimates indicating it held over 49% of the market share in 2022. This dominance is driven by the rising incidence of cancer globally, necessitating advanced diagnostic tools for effective detection and treatment planning.

Nuclear Imaging Equipment Market, By End-User

• Hospitals
• Imaging Centers
• Academic & Research Centers

Based on End-User, the market is fragmented into Hospitals, Home Care Settings, Ambulatory Surgery Centers, and Laboratories and Clinics. The hospitals segment accounted for over 52.75% of the nuclear imaging equipment market in 2023. This significant share reflects the extensive use of nuclear imaging technologies in hospital settings for various diagnostic procedures.

Nuclear Imaging Equipment Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the World

Based on Geography, the Global Nuclear Imaging Equipment Market is classified into North America, Europe, Asia Pacific, and the Rest of the World. North America accounted for approximately 42% of the global nuclear imaging equipment market in 2023. This significant share reflects the region's advanced healthcare infrastructure and high demand for diagnostic imaging technologies.

Key Players

The "Global Nuclear Imaging Equipment Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are DIGIRAD CORPORATION, Neusoft Corporation, CANON MEDICAL SYSTEMS CORPORATION, Absolute Imaging, Inc., pectrum Dynamics, CMR Naviscan., TTG Imaging Solutions, Lucero Dynamics, Berthold Technologies GmbH & COKG, and Siemens Healthineers. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above- mentioned players globally.

• Nuclear Imaging Equipment Market Recent Developments
• In March 2023, Digirad Corporation launched its nSPEED 3D reconstruction software, which enhances imaging speed and reduces patient dosing This software is part of Digirad's commitment to advancing nuclear imaging technology and improving patient comfort.
• In April 2023, Canon Medical Systems introduced the Cartesion Prime Digital PET- CT system, which features advanced AI technology for enhanced image quality and speed. This system is designed to improve disease pathology assessment and facilitate tailored treatment approaches.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET, BY PRODUCT

• 5.1 Overview
• 5.2 SPECT Systems
• 5.3 Hybrid PET Systems
• 5.4 Planar Scintigraphy

6 GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET, BY APPLICATION

• 6.1 Overview
• 6.2 Oncology
• 6.3 Cardiology
• 6.4 Neurology
• 6.5 Others

7 GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET, BY END-USER

• 7.1 Overview
• 7.2 Hospitals
• 7.3 Imaging Centers
• 7.4 Academic and Research Centers
• 7.5 Others

8 GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET, BY GEOGRAPHY

• 8.1 Overview
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 U.K.
  • 8.3.3 France
  • 8.3.4 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Rest of Asia Pacific
• 8.5 Rest of the World
  • 8.5.1 Latin America
  • 8.5.2 Middle East & Africa

9 GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET COMPETITIVE LANDSCAPE

• 9.1 Overview
• 9.2 Company Market Ranking
• 9.3 Key Development Strategies

10 COMPANY PROFILES

• 10.1 Siemens AG
  • 10.1.1 Overview
  • 10.1.2 Financial Performance
  • 10.1.3 Product Outlook
  • 10.1.4 Key Developments
• 10.2 GE Healthcare
  • 10.2.1 Overview
  • 10.2.2 Financial Performance
  • 10.2.3 Product Outlook
  • 10.2.4 Key Developments
• 10.3 Philips Healthcare
  • 10.3.1 Overview
  • 10.3.2 Financial Performance
  • 10.3.3 Product Outlook
  • 10.3.4 Key Developments
• 10.4 Digirad Corporation
  • 10.4.1 Overview
  • 10.4.2 Financial Performance
  • 10.4.3 Product Outlook
  • 10.4.4 Key Developments
• 10.5 Surgiceye GmbH
  • 10.5.1 Overview
  • 10.5.2 Financial Performance
  • 10.5.3 Product Outlook
  • 10.5.4 Key Developments

11 Appendix

• 11.1 Related Research